Scientists from King’s have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.

For students of black ethnicity embarking on their research career Applications for 2026 PhD studentships are open! Application through Cancer Research UK/ Windsor Fellowship required in addition! W...

The rise of antifungal resistance and limited treatment options highlight the urgent need for new drug classes. <i>Candida auris</i> is a serious global health threat with few effective therapies. In ...

King’s and the UK Health Security Agency (UKHSA) have been awarded a joint grant to develop efflux-resistant antibiotics for treating lung infections in people with cystic fibrosis (CF).